As a founder-managed company, it was a key requirement for us to find an investment company as a partner that understands and supports the vision we developed. We found, with SHS.
Johannes Kirchmair
Co-Founder of Single Use Support GmbH
European Healthcare Champions
We build European healthcare champions. To this end, we invest in fast-growing companies in the healthcare sector and help in particular to open up new markets, round off the product portfolio, in succession situations and in financing company acquisitions.
The focus of our investments is on holdings in the areas of medical technology, life sciences & services, diagnostics & tools and digital health. The geographical focus of our investments includes the DACH region as well as other selected European countries.
SHS – Partner for growth and internationalization
Our growth capital investments focus is on companies with market-ready products and technologies in order to develop them into market leaders in a joint partnership.
Hereby, SHS does not see itself as a technology scout or even a passive financial investor, but as a co-partner who brings not only capital, but also industry expertise and a long-standing network into a partnership. We are happy to invest in consortia together with private and institutional co-investors. In addition to classic capital increases, secondary transactions, e.g. of business angel shares, are also possible.
As Germany's leading growth investor, we are familiar with all challenges in the healthcare sector and bring to our partnerships not only many years of industry experience, but also synergy effects from our portfolio.
In principle, various investment situations are possible for SHS in the field of growth capital, such as:
As a founder-managed company, it was a key requirement for us to find an investment company as a partner that understands and supports the vision we developed. We found, with SHS.
Johannes Kirchmair
Co-Founder of Single Use Support GmbH
Summary
Highly innovative dental implant system company – designed and manufactured in Switzerland. TRI® offers the best-in-class digital portfolio and is additionally developing a Digital-Implant which integrates the first-ever dental implant-connection specifically designed for CAD/CAM and 3D-printed prosthetics and thus allows for the connection of a ceramic crown directly to the implant, eliminating the need for an abutment.
General
Name: | TRI Dental Implants Int. AG |
HQ: | Hünenberg, Switzerland |
Industry: | MedTech |
Subsector: | Dental |
Phase: | Growth |
Website
https://tri-implants.swiss/de/USP
Website
https://tri-implants.swiss/de/Summary
AOT is a Swiss MedTech company developing surgical solutions by integrating optics, robotics and digital technologies. The company’s vision is to significantly improve outcomes of osteotomies by offering digital surgical solutions. Thus, the company has developed CARLO®, the world’s first contact-free laser osteotome which allows to overcome the limitations of interventional mechanical instruments used today. The company’s solutions shall improve patient recovery times, reduce complication rates and lower overall procedure costs.
General
Name: | AOT AG |
HQ: | Basel, Switzerland |
Industry: | MedTech |
Subsector: | Surgical Robotics |
Phase: | Growth |
Website
https://aot.swiss/USP
Website
https://aot.swiss/Summary
Selfapy is Germany’s leading provider of online therapy for mental health. Selfapy offers psychologically guided, anonymous, and flexible therapy programs to people suffering from psychological disorders. The three-month programs were developed together with experienced psychotherapists and are based on the principles of cognitive behavioural therapy. Covered indications include Depression, Anxiety Disorders, Burnout, Eating Disorders or Stress.
General
Name: | Selfapy GmbH |
HQ: | Berlin, Germany |
Industry: | MedTech |
Subsector: | Digital Health |
Phase: | Growth |
Website
https://www.selfapy.de/USP
Website
https://www.selfapy.de/SHS – Partner for business successions and expansions
As a partner for medium-sized companies, we bring not only capital but also strategic support and access to our extensive network in the healthcare sector into a partnership. The companies benefit, for example, from our cooperation with the leading health insurance companies or access to key-opinion leaders within the medical technology sector.
We have a long-term investment approach. The goal of every SHS investment is to ensure that the companies are well-prepared for the future and to help them achieve a strong market position. Information about our company history can be found here.
We are also happy to invest in consortia together with co-investors. Our co-investors benefit from our many years of sector expertise.
In principle, various investment opportunities are possible for SHS in the private equity sector, such as:
It was important for me to find a partner with sector expertise. I expect the cooperation with SHS to strengthen our product development and marketing, as well as support in meeting the regulatory challenge.
Reinhold Blazejewski
Managing Director of Blazejewski MEDI-TECH GmbH
Summary
Company with globally-leading devices for the diagnostics of pulmonary function. ndd’s EasyOne® is market-leader in spirometry, ndd’s EasyOne Pro® enables PoC testing of the important pulmonary and cardio-pulmonary markers. ndd’s products are chosen for many and highly-regarded clinical trials (e.g. COPD Gene), including clinical trials of the pharmaceutical industry.
General
Name: | ndd Medizintechnik AG |
HQ: | Zurich, Switzerland |
Industry: | Diagnostics |
Subsector: | Respiratory |
Phase: | Growth |
Website
https://www.ndd.ch/USP
Website
https://www.ndd.ch/Summary
Production and sales of medical aids like fixations and pads for the intensive care, anaesthetic and nursing sectors especially:
General
Name: | Novo Klinik-Service GmbH |
HQ: | Bergheim, Germany |
Industry: | MedTech |
Subsector: | Respiratory |
Phase: | SME |
Website
https://www.novo-med.deUSP
Website
https://www.novo-med.deSummary
CAM Bioceramics is a contract development and manufacturing organization of orthobiologic calcium phosphates (CaP) and calcium hydroxy appetite (CaHa) with a focus on MedTech and Life Science applications. The company was founded in 1985 as a spin-off from the University of Leiden and was among the first companies to provide innovative CaHA plasma-sprayed coatings on orthopedic implants. The company is facing strong and growing customer demand, especially in the segments for CaHa powders for the coating of orthopedic implants and dermal fillers (reducing wrinkles in facial applications).
General
Name: | CAM Bioceramics B.V. |
HQ: | Leiden, Netherlands |
Industry: | Outsourcing & Healthcare Service |
Subsector: | CDMO |
Phase: | SME |
Website
https://cambioceramics.com/USP
Combination of excellent product know-how at the intersection of chemistry, material science and biology, production capabilities & capacities at industrial scale as well as outstanding customer service.
Website
https://cambioceramics.com/